Cancer Registry Software Market Size, Share, Growth Analysis, By Type (Standalone Software, Integrated Software), By Deployment Model (On-premises and Cloud-based), By Database, By Functionality, By End User, By Region - Industry Forecast 2025-2032.


Report ID: SQMIG35G2301 | Region: Global | Published Date: November, 2024
Pages: 166 |Tables: 86 |Figures: 71

Cancer Registry Software Market Insights

Cancer Registry Software Market size was valued at USD 70.67 Million in 2023 and is poised to grow from USD 78.09 Million in 2024 to USD 191.81 Million by 2032, growing at a CAGR of 10.5% during the forecast period (2025-2032).

A cancer registry is a software database used to arrange, gather, and preserve patient data to assess therapy results. This program facilitates the creation of cancer registries, information management, and access. The need for effective cancer management and the growing desire to lower healthcare expenses while enhancing care quality are what are driving the market's expansion. The market is being driven by the growing use of cancer patient registry data for marketing surveillance and the increased deployment of EHRs. Product approvals and debuts are other factors in expanding the market.

The need for appropriate, streamlined, and optimized workflows as well as a reduction in physician workloads are driving the market's expansion, which is primarily responsible for the increased use of integrated software in the healthcare sector. The market will grow more quickly over the projection period due to additional factors such the new government's emphasis on population growth, health management, investments in the healthcare industry, and the elimination of increased healthcare expenses. Numerous advantages, such as efficient workflow leadership, automated case registries, and the rising cancer incidence, are expected to contribute to the anticipated increase in the use of cancer registry software. Furthermore, a lot of government organizations are working on the issue, and encouraging the creation of cancer registries is expected to hasten market growth.

Market snapshot - 2025-2032

Global Market Size

USD 70.67 Million

Largest Segment

Commercial Databases

Fastest Growth

Integrated Software

Growth Rate

10.5%

Global Cancer Registry Software Market ($ Mn)
Country Share by North America (%)

To get more reports on the above market click here to Buy The Report

Cancer Registry Software Market Segmental Analysis

Global Cancer Registry Software Market is segmented by Type, Deployment Model, Database, Functionality, end user and region. Based on Type, the market is segmented into Standalone Software, Integrated Software. Based on Deployment Model, the market is segmented into On-premises, Cloud-based. Based on Database, the market is segmented into Commercial Databases, Public Databases. Based on Functionality, the market is segmented into Cancer Reporting to Meet State & Federal Regulations, Patient Care Management, Product Outcome Evaluation, Medical Research and Clinical Studies. Based on end user, the market is segmented into Government Organizations & Third-party Administrators (TPAS), Hospitals & Medical Practices, Pharmaceutical, Biotechnology, & Medical Device Companies, Private Payers, Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa. 

Analysis by Type

The market for cancer registry software is categorized into standalone and integrated software, with integrated software commanding the largest share and continuing to dominate. Recent advancements in integrated solutions are driving innovation in data management, real-time analytics, and patient tracking. These state-of-the-art procedures are enhancing the efficiency and effectiveness of cancer registry activities. Integrated software excels due to its ability to consolidate various information-gathering systems, streamlining operations and ensuring consistency in data handling. As healthcare increasingly relies on comprehensive and coordinated approaches to manage cancer data, the demand for integrated software is expected to grow, further solidifying its pivotal role in improving cancer care and outcomes.

Standalone software is rapidly becoming the fastest-growing segment in the global cancer registry software market, primarily due to its flexibility and specialized functionality. Unlike integrated solutions, standalone systems offer unique features tailored to specific registries, making them easily customizable and deployable. This customization is particularly attractive to smaller or specialized cancer centers that seek budget-friendly, scalable solutions that address their unique requirements without the complexities of larger integrated systems. The ability to implement standalone software quickly and effectively allows these centers to enhance their data management capabilities while maintaining cost efficiency. As a result, the demand for standalone cancer registry software is expected to rise, reflecting the diverse needs of healthcare providers in managing cancer data.

Analysis by Deployment Model

On-premises solutions in the global cancer registry software market have become key players due to their enhanced security features and flexible integration capabilities. These systems maintain a dominant position by providing excellent data governance and ensuring compliance with strict regulatory requirements. Their ability to connect seamlessly with existing infrastructure addresses concerns about data protection and system reliability, which are critical for healthcare organizations. Additionally, these systems help maintain operational credibility in cancer registry management, enabling healthcare providers to effectively manage data while safeguarding patient confidentiality. The combination of security, reliability, and compliance makes on-premises software an essential choice for institutions focused on delivering high-quality cancer care.

The fastest-growing segment in the cancer registry software market is cloud-based solutions, thanks to their scalability, cost-effectiveness, and easy access. These systems allow real-time data sharing and remote access, meaning users can access information from anywhere without needing heavy on-site hardware. By using cloud technology, healthcare institutions can implement cancer registry software that is modern, efficient, and adaptable to their needs. Cloud-based solutions make it simple to update the software without disruptions, which is a significant advantage for busy healthcare environments. This trend reflects a shift towards more efficient, accessible, and collaborative approaches in handling cancer registry data.

Global Cancer Registry Software Market By Type (%)

To get detailed analysis on other segments, Request For Free Sample Report

Cancer Registry Software Market Regional Insights

The global cancer registry software market is primarily dominated by North America due to its advanced healthcare infrastructure, significant amounts spent on medical research, and strict regulatory regimes. Moreover, the region enjoys high adoption of sophisticated technologies and an extensive network of cancer research institutions and healthcare providers. Furthermore, cancer treatment and database management projects driven by governments together with their funding tend to accelerate the pace of the market. The leadership in this segment is attributed to significant participants in the industry and continuous advancement of software applications meant for use in healthcare systems within North America.

Considering the rising need for digitization of health care and regulatory compliance, Europe is the fastest growing region in the global cancer registry software market, thus its boom in this field. The complex data protection rules set out by the European Union and money available for research on different types of cancers are stimulating usage of new generation cancer registries. Also, this blog post highlights how the region's pledge to better cancer care through combined and joint methods prompts the application of advanced software. In addition, an increased focus on personalized medicine and investments in healthcare spur demand for creative cancer registry systems among European nations.

Global Cancer Registry Software Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Cancer Registry Software Market Dynamics

Drivers

Advancing Population Health Management

  • Building cancer registries are being aided by activities from several government agencies to reduce cancer incidence. Government organizations everywhere are attempting to digitize and integrate healthcare systems, including the creation of computerized illness registries, in response to the growing demand for population health management and the interchange of health information.

An Increase in Accountable Care Organisations

  • An alliance of healthcare providers known as Accountable Treatment Organizations (ACOs) provides efficient chronic illness management and coordinated treatment. The attainment of healthcare quality objectives and outcomes that save money for the healthcare delivery system is a prerequisite for these organizations' payment in global cancer registry software market.

Restraints

Concerns About Data Security and Privacy

  • Family member information is typically included with health information. Therefore, in the event of a data breach, patients' and third parties' private or confidential information may end up in the wrong hands. Currently, governments in many developed economies are finding it difficult to balance the competing demands of information freedom and privacy.

Absence of Integration and Interoperability

  • One of the biggest challenges for software providers is integrating registries into hospital workflows at the point-of-care. Participating in observational studies, many hospitals and physician practices employ multiple data gathering systems and modify their workflow to meet the demands of non-uniform research. Standalone cancer patient registration software not aligning with EHR systems has inhibited the birth of latest treatments.

Request Free Customization of this report to help us to meet your business objectives.

Cancer Registry Software Market Competitive Landscape

The global cancer registry software market is highly competitive and therefore dominated by major players who influence innovation in the market as well as its growth. Some of the key international companies include IBM Watson Health, Oracle Corporation and Siemens Healthineers that are engaged in data management, analytics and integration solutions. They use advanced technologies to improve cancer registries, increase the accuracy of information and facilitate clinical research making them stand out among others in this fast-changing marketplace.

Top Player’s Company Profiles

  • IBM Watson Health 
  • Oracle Corporation 
  • Siemens Healthineers 
  • Cerner Corporation 
  • Epic Systems Corporation 
  • MEDITECH 
  • Allscripts Healthcare Solutions 
  • McKesson Corporation 
  • Philips Healthcare 
  • GE Healthcare 
  • Inova Health System 
  • Varian Medical Systems 
  • Roche Diagnostics 
  • TomoTherapy Inc. 
  • Health Information Systems 
  • Elekta 
  • ONCO, Inc. 
  • Conduent, Inc. 
  • Ordinate Corporation 
  • Volpara Health Limited

Cancer Registry Software Key Market Trends

  • Comprehensive Data Management and Global Adoption: Notable trends in the global cancer registry software market reflect the changing face of oncology care and the growing emphasis on comprehensive management of cancer data. An acute tendency in the world is the growth in the utilization of cancer registry software systems by hospitals. These software systems are significant for efficiently collecting, processing and arranging patient information regarding cancer.
  • AI and Data Analytics Revolutionizing Cancer Registry Software: Technological developments in artificial intelligence (AI) and data analytics are significantly influencing market trends in the cancer registry software sector. Predictive modelling, trend analysis, and data abstraction are made more effective by the incorporation of AI algorithms into cancer registry software.

Cancer Registry Software Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

As per SkyQuest analysis, in conclusion, the global cancer registry software market is experiencing robust growth driven by advancements in technology, government initiatives, and the need for effective cancer data management. Integrated software solutions are enhancing data accuracy and efficiency, while standalone systems offer flexibility for specialized needs.

On demand models of both on-premises and cloud are increasing as North America cheer leads with its advanced infrastructure, whereas Europe has become the fastest growing region by concentrating more on digitalization and compliance with regulations Flexibility to rise above data security and integration issues, Management of cancer care reflects a bigger shift in the industry.

Report Metric Details
Market size value in 2023 USD 70.67 Million
Market size value in 2032 USD 191.81 Million
Growth Rate 10.5%
Base year 2024
Forecast period 2025-2032
Forecast Unit (Value) USD Million
Segments covered
  • Type
    • Standalone Software, Integrated Software
  • Deployment Model
    • On-premises, Cloud-based
  • Database
    • Commercial Databases, Public Databases
  • Functionality
    • Cancer Reporting to Meet State & Federal Regulations, Patient Care Management, Product Outcome Evaluation, Medical Research and Clinical Studies
  • End-User
    • Government Organizations & Third-party Administrators (TPAS), Hospitals & Medical Practices, Pharmaceutical, Biotechnology, & Medical Device Companies, Private Payers, Research Centers
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • IBM Watson Health 
  • Oracle Corporation 
  • Siemens Healthineers 
  • Cerner Corporation 
  • Epic Systems Corporation 
  • MEDITECH 
  • Allscripts Healthcare Solutions 
  • McKesson Corporation 
  • Philips Healthcare 
  • GE Healthcare 
  • Inova Health System 
  • Varian Medical Systems 
  • Roche Diagnostics 
  • TomoTherapy Inc. 
  • Health Information Systems 
  • Elekta 
  • ONCO, Inc. 
  • Conduent, Inc. 
  • Ordinate Corporation 
  • Volpara Health Limited
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Cancer Registry Software Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Cancer Registry Software Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Cancer Registry Software Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cancer Registry Software Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cancer Registry Software Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Cancer Registry Software Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Cancer Registry Software Market size was valued at USD 70.67 Million in 2023 and is poised to grow from USD 78.09 Million in 2024 to USD 191.81 Million by 2032, growing at a CAGR of 10.5% during the forecast period (2025-2032).

The global cancer registry software market is highly competitive and therefore dominated by major players who influence innovation in the market as well as its growth. Some of the key international companies include IBM Watson Health, Oracle Corporation and Siemens Healthineers that are engaged in data management, analytics and integration solutions. They use advanced technologies to improve cancer registries, increase the accuracy of information and facilitate clinical research making them stand out among others in this fast-changing marketplace. 'IBM Watson Health ', 'Oracle Corporation ', 'Siemens Healthineers ', 'Cerner Corporation ', 'Epic Systems Corporation ', 'MEDITECH ', 'Allscripts Healthcare Solutions ', 'McKesson Corporation ', 'Philips Healthcare ', 'GE Healthcare ', 'Inova Health System ', 'Varian Medical Systems ', 'Roche Diagnostics ', 'TomoTherapy Inc. ', 'Health Information Systems ', 'Elekta ', 'ONCO, Inc. ', 'Conduent, Inc. ', 'Ordinate Corporation ', 'Volpara Health Limited'

Building cancer registries are being aided by activities from several government agencies to reduce cancer incidence. Government organizations everywhere are attempting to digitize and integrate healthcare systems, including the creation of computerized illness registries, in response to the growing demand for population health management and the interchange of health information.

Comprehensive Data Management and Global Adoption: Notable trends in the global cancer registry software market reflect the changing face of oncology care and the growing emphasis on comprehensive management of cancer data. An acute tendency in the world is the growth in the utilization of cancer registry software systems by hospitals. These software systems are significant for efficiently collecting, processing and arranging patient information regarding cancer.

The global cancer registry software market is primarily dominated by North America due to its advanced healthcare infrastructure, significant amounts spent on medical research, and strict regulatory regimes. Moreover, the region enjoys high adoption of sophisticated technologies and an extensive network of cancer research institutions and healthcare providers. Furthermore, cancer treatment and database management projects driven by governments together with their funding tend to accelerate the pace of the market. The leadership in this segment is attributed to significant participants in the industry and continuous advancement of software applications meant for use in healthcare systems within North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Cancer Registry Software Market

Report ID: SQMIG35G2301

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE